Time Course Profile of Adverse Events of Interest and Serious Adverse Events With Darolutamide in the ARAMIS Trial

被引：0

作者：

Grabbert, Markus ^{[1
]}

Gratzke, Christian ^{[1
]}

Fizazi, Karim ^{[2
]}

Shore, Neal ^{[3
]}

Smith, Matthew ^{[4
]}

Feyerabend, Susan ^{[5
]}

Carles, Joan ^{[6
]}

Lebret, Thierry ^{[7
]}

Vjaters, Egils ^{[8
]}

Werbrouck, Patrick ^{[9
]}

Miskic, Marina ^{[10
]}

Schmall, Anja ^{[11
]}

Le Berre, Marie Aude ^{[12
]}

Borghesi, Gustavo ^{[13
]}

Verholen, Frank ^{[14
]}

机构：

[1] Univ Hosp Freiburg, Freiburg, Germany

[2] Univ Paris Saclay, Inst Gustave Roussy, Villejuif, France

[3] Carolina Urol Res Ctr, Myrtle Beach, SC USA

[4] Massachusetts Gen Hosp, Boston, MA USA

[5] Studienpraxis Urol, Nuertingen, Germany

[6] Hosp Univ Vall dHebron, Vall dHebron Inst Oncol, Barcelona, Spain

[7] Hop Foch, Suresnes, France

[8] P Stradins Clin Univ Hosp, Riga, Latvia

[9] AZ Groeninge, Kortrijk, Belgium

[10] Bayer Consumer Care AG, Basel, Switzerland

[11] Bayer Vital GmbH, Leverkusen, Germany

[12] Bayer Healthcare SAS, Loos, France

[13] Bayer AG, Berlin, Germany

[14] Bayer Healthcare SAS, Basel, Switzerland

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2022年 / 45卷 / SUPPL 3期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

327

引用

页码：105 / 105

页数：1

共 50 条

[41] Adverse events and preventable adverse events in children
Woods, D
Thomas, E
Holl, J
Altman, S
Brennan, T
PEDIATRICS, 2005, 115 (01) : 155 - 160
[42] Adverse events in British hospitals - Adverse events may occur whatever course of action is pursued
Griffith, D
Diggory, P
Mehta, A
BRITISH MEDICAL JOURNAL, 2001, 322 (7299): : 1426 - 1426
[43] Adverse Events of Special Interest and Pneumococcal Vaccination
Santuccio, C.
Ippolito, F. Menniti
Tartaglia, L.
Da Cas, R.
Trotta, F.
Traversa, G.
DRUG SAFETY, 2011, 34 (10) : 889 - 889
[44] The Effects of Patient Blood Pressure on the Occurrence of Serious Adverse Events in the ENDURANCE Trial
Cowger, J. A.
Rogers, J. G.
Milano, C. A.
Teuteberg, J. J.
Mokadam, N. A.
Birks, E. J.
Boyce, S. W.
Aaronson, K. D.
Pagani, F. D.
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S193 - S194
[45] Serious Adverse Events Among SPRINT Trial Participants Taking Statins at Baseline
Huesch, Marco D.
DRUGS IN R&D, 2017, 17 (04) : 623 - 629
[46] Serious Adverse Events Among SPRINT Trial Participants Taking Statins at Baseline
Marco D. Huesch
Drugs in R&D, 2017, 17 : 623 - 629
[47] Adverse events in diabetes drug trial
Pechlaner, Christoph
LANCET, 2009, 374 (9696): : 1144 - 1144
[48] Adverse-events fraud trial
Michael Francisco
Nature Biotechnology, 2010, 28 (11) : 1142 - 1142
[49] Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
Kingsbury, Colleen M.
Zvorsky, Ivori
Spelman, Kevin
DRUGS-REAL WORLD OUTCOMES, 2024, 11 (04) : 669 - 678
[50] THE ASSOCIATION BETWEEN ANTIHYPERTENSIVE TREATMENT AND SERIOUS ADVERSE EVENTS BY PREVIOUS HISTORY OF ADVERSE EVENTS: AN OBSERVATIONAL COHORT STUDY
Sheppard, James
Koshiaris, Constantinos
Stevens, Richard
Lay-Flurrie, Sarah
Banerjee, Amitava
Bellows, Brandon
Clegg, Andrew
Hobbs, Richard
Payne, Rupert
Swain, Subhashsia
Usher-Smith, Juliet
McManus, Richard
JOURNAL OF HYPERTENSION, 2023, 41 : E84 - E84

← 1 2 3 4 5 →